arrow
A

Ann-Kathrin Ozga

University of Hamburg
H指数:19
被引数:1,813

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Patient-centred interprofessional teleconsultation for post-viral symptom complexes in German primary care—protocol for the cluster-randomised controlled COVI-Care M-V trial

以患者为中心的多专业远程会诊在德国初级保健中用于病毒后症状综合征的干预——COVI-Care M-V试验集群随机对照试验方案

2025-10-030
OAAI
Comparison of the Equivalence of Aspergillus Antigen and PCR Results Between Non-Directed Bronchial Lavage and Bronchoalveolar Lavage-A Prospective Exploratory Pilot Study in Critically Ill Patients

非定向支气管肺泡灌洗与支气管肺泡灌洗中曲霉菌抗原和PCR结果等效性的比较——一项在危重患者中的前瞻性探索性试点研究

MYCOSES
IF3.1
2025-02-030
OA
Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome

TIPS对肝硬化的再补偿减少了上皮细胞死亡标志物,转化为改善的临床结果

2024-11-120
OAAI
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: dThe NOAH-AFNET 6 Trial
2024-09-038
OAAI
Stepped, evidence-based and integrated care service model vs. usual care for mental disorders: A randomized controlled trial (RECOVER)
2024-09-011
PRE
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
2024-04-095
OAAI
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
2023-11-1225
OAAI
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

心房高速率发作患者的依多沙班抗凝治疗

2023-09-28157
OA